stars 1 stars 2 stars 3

Regivet BV is a very experienced independent Dutch consulting firm specialized in the development and registration of veterinary pharmaceuticals in Europe (National/MRP/DCP/CP). Coming from a successful development team in a commercial competitive environment we realize how important it is to get a product authorized as quickly as possible and in the most cost effective manner. We also understand the simultaneous need to present a commercially attractive product in order to be successful in the veterinary pharmaceutical market, i.e. better palatability, stability, additional indications or target species. The interaction between the pharmaceutical development team and veterinarians within Regivet is therefore of key importance and starts even before any development work is done. By keeping the complete development in-house, this interaction is optimized during the whole procedure.

Regivet BV Questions

The Regivet BV annual revenue was $3 million in 2026.

Nynke Deckers is the Director Clinical Development of Regivet BV.

23 people are employed at Regivet BV.

Regivet BV is based in Oirschot, North Brabant.

The NAICS codes for Regivet BV are [32, 32541, 325, 3254].

The SIC codes for Regivet BV are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users